Pneumagen’s Neumifil for combating COVID-19 featured in SCRIP’s 10 to watch at BIO-Europe Digital

It is October, which features a high point with BIO-Europe Digital, one of Europe’s largest life sciences gatherings, now fully online. We are delighted that Pneumagen is featured in Scrip’s 10 to Watch—A spotlight presentation track curated by Scrip from Informa Pharma Intelligence. Scrip’s editorial team has identified 10 emerging companies displaying innovative promise in drug discovery and development. Hear our CEO, Douglas Thomson talk about all we’re doing to develop Neumifil, a self-administered intranasal product, as a pan-viral solution for the prevention and treatment of infectious diseases including influenza, RSV and COVID-19. Our on-demand presentation is viewable by all registered delegates.